We developed criteria to identify women at increased risk for chlamydial infection in a low-prevalence population
— the enrollees of a health maintenance organization (HMO).17 We now report on a randomized, controlled trial in the same population that was designed to evaluate whether the use of these criteria to select women to be tested for cervical chlamydial infection would reduce the incidence of pelvic inflammatory disease.